Professional Documents
Culture Documents
2013 GLS Agenda PDF
2013 GLS Agenda PDF
2013 GLS Agenda PDF
Agenda
Friday, May 17, 2013
I. Drugs and Vaccines Moderator: Simon Lovestone, MB, Ph.D. 8:30 AM Opening Welcome: Larry Gold, Ph.D., MCDB, CU and SomaLogic Complexity: Rube Goldberg Was Merely Linear 9:00 AM Christopher T. Walsh, Professor, Harvard Medical School Antibiotics Past, Present, and Future: At the Academic/Biotech Interface 9:45 AM Steven G. Reed, Ph.D., Founder, President and Chief Scientic Ofcer, Infectious Disease Research Institute (IDRI) Novel Adjuvants for New Vaccines 10:30 AM Break 11:00 AM Peter S. Kim, Ph.D., Former President, Merck Research Laboratories Towards an HIV Vaccine 11:45 AM John Swindle, Ph.D., President and CEO, CompleGen, Inc. Drug Discovery: Innitely Complex but Dont Overthink It 12:30 PM Lunch II. Drugs and Diagnostics Moderator: Pippa Marrack, Ph.D. 2:00 PM Mat Todd, Ph.D., University of Sydney Open Source Drug Discovery - A Limited Liability Tutorial 2:45 PM Lakshmi A. Devi, Ph.D., Professor, Mount Sinai School of Medicine Big Science on a Small Budget: Neuropeptide Receptors and Drug Development 3:30 PM Break 4:00 PM Charles Cantor, Ph.D., Chief Scientic Ofcer, Sequenom, Inc. Noninvasive Personal Genomics 4:45 PM David Juncker, Ph.D., Associate Professor, Department of Biomedical Engineering, McGill University The Transformation of Society by Microchips and Scalable Technologies: From Computers to Healthcare 5:30 PM Closing Remarks
Admission is free, but seats are limited. Please register through Colorado Biosciences Association - www.cobioscience.com